EUVIMEDEUVIMED entdecken
Open Access

Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer

Abigael Odwuor, Percy Lee, Joe Y Chang, Saumil Gandhi, Zhongxing Liao, Steven H Lin, Aileen Chen, Quynh-Nhu Nguyen, Michael S O'Reilly, Stephen G Chun, Julianna Bronk, David Qian und 1 weitere

Clinical Lung Cancer · 2025

DOI: 10.1016/j.cllc.2025.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2025. Verfasst von Abigael Odwuor und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, American Society for Radiation Oncology, Henry Ford Health System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Salvage re-irradiation is increasingly utilized to manage non-small cell lung cancer (NSCLC) locoregional recurrence or new lung primaries in previously treated areas. There is sparse information on efficacy and toxicity profile. We report a large experience of patients treated with multiple courses of definitive radiation for new and recurrent NSCLC. METHODS AND MATERIALS: Medical records of patients who underwent ≥ 3 definitive thoracic radiation therapy (RT) courses for new or recurrent NSCLC at our cancer center from 2012 through 2021 were retrospectively reviewed following institutional review board approval. Toxicity was graded per Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 and outcomes were estimated using Kaplan-Meier. RESULTS: Among 51 patients meeting inclusion criteria, there were 161 definitive thoracic RT courses (8 received 4 courses). Of these courses, 119 (74%) entailed SBRT for localized lesions; the remaining were conventional fractionation (half included concurrent chemotherapy). Seventeen patients (33%) received SBRT for every thoracic treatment course. There was overlap of treatment fields between separate courses for 38 patients (75%). Following last thoracic RT, median overall survival (OS) was 2.9 years (range, 1.5-4.4) and progression-free survival (PFS) was 14-months (range, 8.5-19). Three-year estimated OS (±standard error) was 81% (± 10%) for patients who received SBRT for every course and 32% (± 9%) among those treated with mixed modality. Overall Grade 3 toxicity incidence was 6%, no Grade 4 or 5 events. CONCLUSION: Definitive thoracic radiation can be a safe and effective local control modality (despite multiple prior treatments) and should be considered when planning multidisciplinary salvage therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleAgedRetrospective StudiesMiddle AgedAged, 80 and overSalvage TherapySurvival RateFollow-Up StudiesAdultTreatment OutcomeRadiosurgery

Stichwörter der Autor:innen

Definitive intentReirradiationSalvage radiationStereotactic body radiation therapyThoracic malignancies

Autor:innen und Institutionen

  • Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: msning@mdanderson.org.

Förderung

  • NCI NIH HHS
  • American Society for Radiation Oncology
  • Henry Ford Health System
  • National Institutes of Health
  • AstraZeneca
  • International Association for the Study of Lung Cancer
  • NRG Oncology
  • American Radium Society

Zitieren

APA

Odwuor, A., Lee, P., Chang, J. Y., Gandhi, S., Liao, Z., Lin, S. H., Chen, A., Nguyen, Q. N., O'Reilly, M. S., Chun, S. G., Bronk, J., Qian, D., & Ning, M. S. (2025). Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2025.04.002

Vancouver

Odwuor A, Lee P, Chang JY, Gandhi S, Liao Z, Lin SH, et al. Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer. Clinical Lung Cancer. 2025. doi:10.1016/j.cllc.2025.04.002

BibTeX
@article{Odwuor2025,
  author = {Odwuor, Abigael and Lee, Percy and Chang, Joe Y and Gandhi, Saumil and Liao, Zhongxing and Lin, Steven H and Chen, Aileen and Nguyen, Quynh-Nhu and O'Reilly, Michael S and Chun, Stephen G and Bronk, Julianna and Qian, David and Ning, Matthew S},
  title = {Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic Radiation Therapy for Non-Small Cell Lung Cancer},
  journal = {Clinical Lung Cancer},
  year = {2025},
  doi = {10.1016/j.cllc.2025.04.002}
}
Kostenlos starten →